Clinical Cancer Research The Science of Cancer Health Disparities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, T.
Right arrow Articles by Zheng, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, T.
Right arrow Articles by Zheng, P.
Clinical Cancer Research Vol. 11, 3614-3623, May 15, 2005
© 2005 American Association for Cancer Research


Human Cancer Biology

A Rare Transporter Associated with Antigen Processing Polymorphism Overpresented in HLAlow Colon Cancer Reveals the Functional Significance of the Signature Domain in Antigen Processing

Tianyu Yang1, Philip E. Lapinski4, Haotian Zhao2, Qunmin Zhou1,3, Huiming Zhang1, Malini Raghavan4, Yang Liu1 and Pan Zheng1

Authors' Affiliations: 1 Division of Cancer Immunology, Department of Pathology and Comprehensive Cancer Center, 2 Graduate Program in Molecular, Cellular, and Developmental Biology, The Ohio State University, 3 OncoImmune, Ltd., Columbus, Ohio, and 4 Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan

Requests for reprints: Pan Zheng, Division of Cancer Immunology, Department of Pathology and Comprehensive Cancer Center, The Ohio State University Medical Center, 129 Hamilton Hall, 1645 Neil Avenue, Columbus, OH 43210. Phone: 614-292-2003; Fax: 614-688-8152; E-mail: zheng-1{at}medctr.osu.edu.

Transporter associated with antigen processing (TAP), a member of the ATP-binding cassette transporter superfamily, is composed of two integral membrane proteins, TAP-1 and TAP-2. Each subunit has a C-terminal nucleotide-binding domain that binds and hydrolyzes ATP to energize peptide translocation across the endoplasmic reticulum membrane. A motif comprising the sequence LSGGQ (called the signature motif) and the amino acid that is immediately C-terminal to this motif are highly conserved in the nucleotide-binding domains of ATP-binding cassette transporters. To search for natural variants of TAP-1 with alterations in or near the signature motif, we sequenced the TAP-1 exon 10 amplified from 103 human colon cancer samples. We found a rare TAP-1 allele with an R>Q alteration at a residue immediately C-terminal to the signature motif (R648) that occurred 17.5 times more frequently in colon cancers with down-regulated surface class I MHC than those with normal MHC levels (P = 0.01). Functional analysis revealed that the Q648 variant had significantly reduced peptide translocation activity compared with TAP-1(R648). In addition, we found that mutations S644R, G645R, G646S, and G646D interfered with TAP-1 activity. TAP-1 G646D, which showed the most severe defect, resided normally in the endoplasmic reticulum and associated with the peptide loading complex, but failed to transport peptide across the endoplasmic reticulum membrane. Thus, a TAP-1 polymorphism adjacent to the signature motif may be a contributing factor for MHC class I down-regulation in colon cancer. Given the widespread defects in DNA mismatch repair in colon cancer, mutations at or near the signature domain can potentially modulate antigen processing.

Key Words: TAP-1 Polymorphism • antigen presentation • structure and function • signature motif • human leukocyte antigens • Polymorphisms related to inflammation, immune response, and oxidative damage in cancer risk • immunomodulation




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. L. Perria, V. Rajamanickam, P. E. Lapinski, and M. Raghavan
Catalytic Site Modifications of TAP1 and TAP2 and Their Functional Consequences
J. Biol. Chem., December 29, 2006; 281(52): 39839 - 39851.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Thammavongsa, G. Raghuraman, T. M. Filzen, K. L. Collins, and M. Raghavan
HLA-B44 Polymorphisms at Position 116 of the Heavy Chain Influence TAP Complex Binding via an Effect on Peptide Occupancy.
J. Immunol., September 1, 2006; 177(5): 3150 - 3161.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.